Atai Life Sciences N.V. (NASDAQ:ATAI) is one of the best multibagger penny stocks to buy right now. ATAI Life Sciences holds a Strong Buy consensus from 8 analysts, with a 12‑month average target of ...

A new clinical trial underway in the Lowcountry is drawing attention for its unconventional — and potentially groundbreaking ...

Your skeleton is 20 pounds of miracle, contributing to your mood, memory, and metabolism. Learn why better mental health may, ...

Lipocine ( ($LPCN) ) has shared an announcement. On December 16, 2025, Lipocine announced that its Phase 3 clinical trial for LPCN 1154, an oral ...

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Courtney Cameron, PharmD, BCACP, about widespread availability of ...

Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company developing potentially first-in-class therapeutics for common dermatologic conditions, today announced ...

The newly granted U.S. patent, No. 12,492,178, includes claims to the drug substance of EMP-01, and is expected to provide exclusivity through 2043. This patent identifies a highly-crystalline, ...

Italian pharmaceutical company Cosmo Pharmaceuticals recently announced that its newly developed male-pattern hair loss treatment achieved significant results in Phase 3 clinical trials. Existing male ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, ...

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said the FDA has received its Abbreviated New Drug Application for KETAFREE (TM), a preservative-free intravenous ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, the 'Company”, 'NRx”), a clinical-stage biopharmaceutical company and HOPE ...

Silymarin, extracted from the seeds of Silybum marianum (milk thistle), has been utilised in traditional medicine for many years and is recognised for its neuroprotective and hepatoprotective ...